Grade My Investments
Home › Free Stock Grades › MDWD

MediWound Ltd. (MDWD) Stock Grade

MDWD · Healthcare

C
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$178.9M
P/E Ratio
—
Revenue Growth (YoY)
-16.1%
Net Margin
-140.8%
Return on Equity
—
Dividend Yield
None

About MediWound Ltd.'s fundamentals

MediWound Ltd. is a biotechnology company with a market capitalization of $178.9 million that is currently unprofitable, with a net margin of -140.8% and a reported net loss in its latest annual statement. The company experienced a significant revenue contraction of 16.1% year-over-year, indicating declining sales performance. The company does not currently pay dividends to shareholders. Traditional valuation metrics like P/E ratio and return on equity are not applicable given the company's loss-making status.

Track MDWD free — no credit card required. Live grade + monthly AI report →